miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
about
MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.Fe₃O₄ Nanoparticles in Targeted Drug/Gene Delivery Systems.Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.
P2860
miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-186 regulates chemo-sensit ...... mall cell lung cancer (NSCLC).
@en
type
label
miR-186 regulates chemo-sensit ...... mall cell lung cancer (NSCLC).
@en
prefLabel
miR-186 regulates chemo-sensit ...... mall cell lung cancer (NSCLC).
@en
P2093
P2860
P356
P1433
P1476
miR-186 regulates chemo-sensit ...... mall cell lung cancer (NSCLC).
@en
P2093
P2860
P304
P356
10.1039/C6MB00576D
P577
2016-09-16T00:00:00Z